Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: A systematic review and network meta-analysis of randomised controlled trials
Individual response determines whether further increases beyond 1.7 mg become necessary or beneficial for your weight loss journey
Research Centre for Working Environment and Human Factors Zierold C, Mings JA, DeLuca HF (2003) Regulation of 25-hydroxyvitamin D324-hydroxylase mRNA by 1,25-dihydroxyvitamin D3 and parathyroid hormone
Similar to many medications, individuals who have been prescribed Ozempic for a prolonged period may encounter withdrawal symptoms upon cessation
In Summary Weight-loss drugsespecially GLP-1 receptor agonists like semaglutide and tirzepatideoffer significant metabolic benefits, but they may carry small, rare risks to eye health, including: NAION (eye stroke) Worsening diabetic retinopathy Increased risk of nAMD Topiramate-specific risks like angle-closure glaucoma Staying informed, proactive, and monitored can help you benefit from these therapies while protecting your vision.
it is about recovering physiology at the bedside
